deferiprone has been researched along with Allergic Encephalomyelitis in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khan, RS | 1 |
Baumann, B | 1 |
Dine, K | 1 |
Song, Y | 1 |
Dunaief, JL | 1 |
Kim, SF | 1 |
Shindler, KS | 1 |
Mitchell, KM | 1 |
Dotson, AL | 1 |
Cool, KM | 1 |
Chakrabarty, A | 1 |
Benedict, SH | 1 |
LeVine, SM | 1 |
2 other studies available for deferiprone and Allergic Encephalomyelitis
Article | Year |
---|---|
Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.
Topics: Animals; Chelating Agents; Deferiprone; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; | 2019 |
Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.
Topics: Administration, Oral; Animals; Cell Division; Deferiprone; Encephalomyelitis, Autoimmune, Experiment | 2007 |